Neurology News and Research

Latest Neurology News and Research

Overnight EEG studies may help inform care for girls with Rett syndrome

In Rett syndrome, a genetic condition affecting girls almost exclusively, mutations in the MECP2 gene cause a regression of language and motor skills starting at 12 to 18 months of age.

8 Aug 2022

Fatigue and headache among the most common symptoms following COVID-19 infections

Fatigue and headache were the most common symptoms reported by individuals an average of more than four months out from having COVID-19, investigators report.

8 Aug 2022

Elevated stress during the pandemic impacted the quality of life for kids with headache disorders

Since the beginning of the COVID-19 pandemic, many pediatric patients who suffer from headaches have experienced more frequent headaches and worsening anxiety and mood, and a new study finds links to stress, decreased physical activity and increased screen time.

5 Aug 2022

Study sheds light on the pathogenic brain mechanisms associated with evolution of anxiety

Monoamine neurotransmitters such as serotonin and dopamine play important roles in our cognitive and emotional functions.

5 Aug 2022

Cognitive rehab may help older adults clear covid-related brain fog

Eight months after falling ill with covid-19, the 73-year-old woman couldn't remember what her husband had told her a few hours before. She would forget to remove laundry from the dryer at the end of the cycle. She would turn on the tap at a sink and walk away.

5 Aug 2022

Discovery could prevent insulin resistance and have significant benefits for people with type 2 diabetes

In a potential game changer for patients with type 2 diabetes, a team of researchers at the Diabetes, Obesity, and Metabolism Institute (DOMI) at the Icahn School of Medicine at Mount Sinai has identified a therapeutic target for the preservation and regeneration of beta cells (β cells) - cells in the pancreas that produce and distribute insulin.

4 Aug 2022

Researchers assess Alzheimer's disease risk and anti-diabetic drugs

In a new study, researchers assessed the genetic variation among targets of Alzheimer's disease risk and anti-diabetic drugs.

3 Aug 2022

New, non-invasive imaging method may help detect an early indicator of glaucoma

A new, non-invasive ocular imaging method may be able to detect an early indicator of glaucoma in time to prevent disease progression and vision loss, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.

2 Aug 2022

Novel subset of immune cells confers fast-acting and lasting protection against ischemic stroke

A unique subset of white blood cells confers fast-acting and lasting protection against ischemic stroke in mice, University of Pittsburgh neurologists and immunologists reported in the Journal of Clinical Investigation today.

1 Aug 2022

Newly developed nanobodies could eventually be used to treat neurocognitive disorders

Proteins called antibodies help the immune system find and attack foreign pathogens. Mini versions of antibodies, called nanobodies — natural compounds in the blood of animals such as llamas and sharks — are being studied to treat autoimmune diseases and cancer.

1 Aug 2022

Gene mutation responsible for hereditary hemochromatosis may be a risk factor for movement disorders

A disorder called hereditary hemochromatosis, caused by a gene mutation, results in the body absorbing too much iron, leading to tissue damage and conditions like liver disease, heart problems and diabetes.

1 Aug 2022

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time.

1 Aug 2022

The Alzheimer’s Association recognizes seven researchers for contributions to the field of dementia science

The Alzheimer’s Association will present seven awards at the Alzheimer’s Association International Conference 2022, recognizing researchers for their varied expertise, noteworthy achievements and innovative contributions to the field of Alzheimer’s and dementia science.

1 Aug 2022

Experts release appropriate use recommendations for Alzheimer’s disease blood biomarkers

Alzheimer’s disease blood biomarkers (BBMs) may revolutionize the diagnosis of Alzheimer’s in the future, but are not yet ready for widespread use, according to a newly-published article by leading international clinicians and researchers convened by the Alzheimer’s Association.

31 Jul 2022

Celebrating the role of aspirin as chemopreventative agent against cancer

A special edition issue of the Aspirin Summaries has been published '125 years of aspirin - the role of aspirin in cancer' issue 2022.

29 Jul 2022

Newly developed nanobody can get through tough brain cells and treat Parkinson’s disease

Proteins called antibodies help the immune system find and attack foreign pathogens. Mini versions of antibodies, called nanobodies - natural compounds in the blood of animals such as llamas and sharks - are being studied to treat autoimmune diseases and cancer.

28 Jul 2022

Weill Cornell Medicine-led consortium secures $14 million grant to study emerging technologies for aging adults

A Weill Cornell Medicine-led consortium has been awarded a five-year, $14.7 million renewal grant from the National Institute on Aging of the National Institutes of Health for a research Center focused on employing emerging and existing technologies to help promote the well-being, quality of life and independence of diverse populations of older adults and provide support for older adults with cognitive impairments.

28 Jul 2022

Physical and mental activities may help reduce dementia risk

Physical and mental activities, such as household chores, exercise, and visiting with family and friends, may help lower the risk of dementia, according to a new study published in the July 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Jul 2022

People who eat more ultra-processed foods may have higher risk of dementia

People who eat the highest amounts of ultra-processed foods like soft drinks, chips and cookies may have a higher risk of developing dementia than those who eat the lowest amounts, according to a new study published in the July 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Jul 2022

Study shows how changing stroke care protocols could improve triage and patient's survival

Implementing severity-based field triage leads to faster treatment and less disability for stroke patients. The research presented today at the Society of NeuroInterventional Surgery's 19th Annual Meeting, and now published online in the Journal of NeuroInterventional Surgery, shows that states that use field-based stroke severity triage as part of their Emergency Medical Systems (EMS) transport protocols give severe stroke patients more rapid access to specially trained neuroendovascular care teams and lifesaving thrombectomy.

27 Jul 2022

Neurology News and Research

Latest Neurology News and Research

Overnight EEG studies may help inform care for girls with Rett syndrome

Fatigue and headache among the most common symptoms following COVID-19 infections

Elevated stress during the pandemic impacted the quality of life for kids with headache disorders

Study sheds light on the pathogenic brain mechanisms associated with evolution of anxiety

Cognitive rehab may help older adults clear covid-related brain fog

Discovery could prevent insulin resistance and have significant benefits for people with type 2 diabetes

Researchers assess Alzheimer's disease risk and anti-diabetic drugs

New, non-invasive imaging method may help detect an early indicator of glaucoma

Novel subset of immune cells confers fast-acting and lasting protection against ischemic stroke

Newly developed nanobodies could eventually be used to treat neurocognitive disorders

Gene mutation responsible for hereditary hemochromatosis may be a risk factor for movement disorders

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

The Alzheimer’s Association recognizes seven researchers for contributions to the field of dementia science

Experts release appropriate use recommendations for Alzheimer’s disease blood biomarkers

Celebrating the role of aspirin as chemopreventative agent against cancer

Newly developed nanobody can get through tough brain cells and treat Parkinson’s disease

Weill Cornell Medicine-led consortium secures $14 million grant to study emerging technologies for aging adults

Physical and mental activities may help reduce dementia risk

People who eat more ultra-processed foods may have higher risk of dementia

Study shows how changing stroke care protocols could improve triage and patient's survival

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Neurology News and Research

Latest Neurology News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in